Trials / Completed
CompletedNCT03384160
Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.
Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Splint-mouth Randomized Double Blind Controlled Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Universidade Estadual Paulista Júlio de Mesquita Filho · Academic / Other
- Sex
- All
- Age
- 16 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The extraction of third molars, a frequent treatment in clinical dental practice, can lead patients to painful symptoms during and after surgery. The dental surgeon must correctly indicate the need for extraction and also provide patients who need this treatment greater comfort and control of pain in the trans and postoperative period. Thus, it is necessary to use an effective local anesthetic favoring the factors inherent to the postoperative and achieving good treatment results.
Detailed description
This study will compare the use of Articaine at 4% to that of Mepivacaine at 2% for lower third molar surgeries semi-included and / or included. I will select 16 patients who require surgical treatment for extraction of third molars, aged between 16 and 40 years at the São Paulo State University. These will participate simultaneously in the two groups: Group 1 mepivacaine (MEP) and Group 2 articaine (ART), and the division will be performed by randomization, so that each patient will have each side (right or left) allocated in different groups. The primary evaluation variable will be to compare the pain index in the immediate postoperative period, using Visual Analog Scale (VAS), and will also analyze Hemodynamic Parameters, such as Patient and Operator satisfaction. The results will be submitted to qualitative and quantitative statistical analysis. The descriptive data will be compared using the statistical analysis of variance (ANOVA) and Tukey test with a significance level of 5%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Group 1 -Pain monitor | Use of the anesthetic Mepivacaine 2% in third molar extraction and evaluation in postoperative |
| DIAGNOSTIC_TEST | Group 2 -Pain monitor | Use of the anesthetic Articaine 4% in third molar extraction and evaluation in postoperative |
Timeline
- Start date
- 2017-12-07
- Primary completion
- 2018-10-30
- Completion
- 2018-12-04
- First posted
- 2017-12-27
- Last updated
- 2019-02-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03384160. Inclusion in this directory is not an endorsement.